# Evaluation of Accelerometer-Based Neuromuscular Monitoring Reliability to Exclude Postoperative Residual Paralysis

> **NCT01503840** · NA · COMPLETED · sponsor: **Fondazione IRCCS Istituto Nazionale dei Tumori, Milano** · enrollment: 20 (actual)

## Conditions studied

- Postoperative Residual Paralysis

## Interventions

- **DRUG:** sugammadex
- **DRUG:** Sodium chloride solution

## Key facts

- **NCT ID:** NCT01503840
- **Lead sponsor:** Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2012-06
- **Final completion:** 2012-07
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2014-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01503840

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01503840, "Evaluation of Accelerometer-Based Neuromuscular Monitoring Reliability to Exclude Postoperative Residual Paralysis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01503840. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*